Results 81 to 90 of about 25,852 (227)

High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

, 2007
http://content.nejm.org/cgi/content/abstract/357/11/1083International audienceHigh-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation has been reported to provide higher response rates and better overall survival than ...
Asli, Bouchra, Piette, Jean-Charles, Moreau, Philippe, Ronco, Pierre, Jaubert, Jérôme, Benboubker, Lofti, Leleu, Xavier, Fermand, Jean-Paul, Lioure, Bruno, Jaccard, Arnaud, Hermine, Olivier, Cogné, Michel, Jardin, Fabrice, Leblond, Véronique, Bridoux, Franck, Recher, Christian, Royer, Bruno, Grosbois, Bernard, Quet, Fabrice   +18 more
core  

The melphalan RI differ between TC classes.

, 2013
The translocation and cyclin D defined TC classification involving early oncogenic events were applied to the HOVON65/GMMG-HD4 data set and in panel A) each of the 8 classes of tumours showed different melphalan RI levels (P-value  = 0.00025). In panel B)
Hans E. Johnsen (222935), Karen Dybkaer (222945), Hartmut Goldschmidt (87325), Gareth J. Morgan (179971), Alexander Schmitz (222922), Martin Bøgsted (116784), Uta Bertsch (500108), Anders E. Bilgrau (500107), Christopher P. Wardell (179958), Julie S. Bødker (500109), Malene K. Kjeldsen (500110)   +10 more
core   +1 more source

Identification of Novel Therapeutic Agent Candidates Through High Throughput Screening With Chemical Library Based on Molecular Subclassification in Canine Histiocytic Sarcoma Cell Lines

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Effective chemotherapy for canine histiocytic sarcoma (CHS) has yet to be established. In our previous study, CHS cell lines were subclassified into two groups based on their gene expression profiles: Group A and Group B. This study aimed to identify novel therapeutic agents that are effective against each CHS subgroup, and we performed high ...
Hiroki Sakuma, Hirotaka Tomiyasu, Mari Takamiya, Yuko Goto‐Koshino, Atsushi Tsukamoto, Makoto Bonkobara, Masaru Okuda   +6 more
wiley   +1 more source

Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma

International Journal of Cancer, Volume 159, Issue 2, Page 339-344, 15 July 2026.
What's new? Uveal melanoma is the most common primary intraocular cancer in adults, and up to half of patients develop metastatic disease, predominantly in the liver, where prognosis remains poor despite promising treatment options. In this study, the authors evaluated the safety and efficacy of administering systemic therapy within 40 days of liver ...
Patrick Kasteleiner, Gerd Grözinger, Jörg Schmehl, Lukas Flatz, Andrea Forschner   +4 more
wiley   +1 more source

Conditioning regimen with melphalan in autologous stem cell transplantation /ASCT) for acute myeloid leukemia: results of retrospective analysis of the italian pediatric group for bone marrow transplantation (AEOP-BMT)

, 2000
Restrospective study on the use of high-dose of melphalan for myeloablative conditioning ...
CESARO, SIMONE, GIORGIANI G., PESSION A., CALORE E., PILLON M., MELONI G., LOCATELLI F., CAPRIA S., MICCIOLO R., MESSINA C.   +9 more
core  

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

eJHaem
Relapse remains the main cause of treatment failure in patients with myeloid malignancies even after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We observed a particularly low incidence of relapse in patients prepared with fludarabine,
Jieling Jiang, Xiaofan Li, Dong Wu, Quanyi Lu, Kourong Miao, Houcai Wang, Xiaoping Li, Yingnian Chen, Shiyuan Zhou, Yali Zhou, Guiping Liao, Chuanhe Jiang, Xiaohong Yuan, Youshan Zhao, Chunkang Chang, Jie Chen, Han Zhu, Ruye Ma, Nainong Li, Xiaolin Yin, Xiaojin Wu, Sanbin Wang, Chun Wang, Jiong Hu   +23 more
doaj   +1 more source

Cutaneous Crystal‐Storing Histiocytosis With Marginal Zone Lymphoma. A Case Report With A Striking Clinical Presentation

Journal of Cutaneous Pathology, Volume 53, Issue 7, Page 576-580, July 2026.
ABSTRACT Cutaneous crystal‐storing histiocytosis (CSH) is an extremely rare histopathologic finding of histiocytes accumulating crystals of immunoglobulin or paraproteins, often associated with lymphoplasmacytic malignancies. It commonly presents in a wide age range of both female and male adults with a history of a lymphoproliferative disorder ...
Ashton Arlen, Brad S. Graham, Gregory A. Hosler, Marsha C. Kinney   +3 more
wiley   +1 more source

Venetoclax‐Integrated Conditioning Strategies Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Neoplasms: A Scoping Review of Emerging Evidence

European Journal of Haematology, Volume 117, Issue 1, Page 117-131, July 2026.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the only potentially curative therapy for many patients with high‐risk myeloid neoplasms, yet relapse and transplant‐related toxicity continue to limit durable benefit.
Mohammed Abdulgayoom, Amaal Gulied, Awni Alshurafa, Shehab F. Mohamed, Mohamed A. Yassin, Afraa Fadul   +5 more
wiley   +1 more source

Melphalan and steroid-hormones

, 1978
This article discusses melphalan and steroid ...
Algie, T., Grant, J.K., Anderson, J.M., Gettinby, G.   +3 more
core  

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

, 2021
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ...
MA Dimopoulos (14653952), S Knop (13404456), SS Yoon (8001779), M Cavo (13404444), K Suzuki (7157597), M Qi (13395564), MV Mateos (14653949), J Ukropec (13404495), P Lucio (13404462), J Bladé (13404609), M Garg (13404486), Z Nagy (9866693), L Pour (13404465), H Pei (13404612), R Van Rampelbergh (13404615), AM Liberati (14653649), J San-Miguel (13404504), C Doyen (13404459), S Iida (13404606), A Kudva (13404492), S Grosicki (13404468), P Campbell (4048558), G Iosava (13404480), T Fujisaki (13404483), A Crepaldi (13404471)   +24 more
core